GH Research (GHRS)
GH Research Statistics
Share Statistics
GH Research has 62.03M shares outstanding. The number of shares has increased by 0% in one year.
Shares Outstanding | 62.03M |
Shares Change (YoY) | 0% |
Shares Change (QoQ) | 0% |
Owned by Institutions (%) | 58.66% |
Shares Floating | 36.29M |
Failed to Deliver (FTD) Shares | 17.94K |
FTD / Avg. Volume | 3.97% |
Short Selling Information
The latest short interest is 1.91M, so 3.67% of the outstanding shares have been sold short.
Short Interest | 1.91M |
Short % of Shares Out | 3.67% |
Short % of Float | 6.27% |
Short Ratio (days to cover) | 30.57 |
Valuation Ratios
The PE ratio is -8.48 and the forward PE ratio is -9.6. GH Research's PEG ratio is -0.02.
PE Ratio | -8.48 |
Forward PE | -9.6 |
PS Ratio | 0 |
Forward PS | 3.8 |
PB Ratio | 1.38 |
P/FCF Ratio | -9.02 |
PEG Ratio | -0.02 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for GH Research.
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 24.49, with a Debt / Equity ratio of 0.
Current Ratio | 24.49 |
Quick Ratio | 24.49 |
Debt / Equity | 0 |
Total Debt / Capitalization | 0.44 |
Cash Flow / Debt | -34.23 |
Interest Coverage | -57.02 |
Financial Efficiency
Return on equity (ROE) is -0.16% and return on capital (ROIC) is -18.74%.
Return on Equity (ROE) | -0.16% |
Return on Assets (ROA) | -0.16% |
Return on Capital (ROIC) | -18.74% |
Revenue Per Employee | $0 |
Profits Per Employee | $-726,265.31 |
Employee Count | 49 |
Asset Turnover | 0 |
Inventory Turnover | n/a |
Taxes
Income Tax | 0 |
Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by 12.3% in the last 52 weeks. The beta is 0.94, so GH Research's price volatility has been higher than the market average.
Beta | 0.94 |
52-Week Price Change | 12.3% |
50-Day Moving Average | 10.37 |
200-Day Moving Average | 10.1 |
Relative Strength Index (RSI) | 33.98 |
Average Volume (20 Days) | 452.35K |
Income Statement
Revenue | n/a |
Gross Profit | -315K |
Operating Income | -41.22M |
Net Income | -35.59M |
EBITDA | -41.15M |
EBIT | n/a |
Earnings Per Share (EPS) | -0.68 |
Balance Sheet
The company has 78.42M in cash and 974K in debt, giving a net cash position of 77.45M.
Cash & Cash Equivalents | 78.42M |
Total Debt | 974K |
Net Cash | 77.45M |
Retained Earnings | -67.94M |
Total Assets | 199.61M |
Working Capital | 145.16M |
Cash Flow
In the last 12 months, operating cash flow was -33.34M and capital expenditures -100K, giving a free cash flow of -33.44M.
Operating Cash Flow | -33.34M |
Capital Expenditures | -100K |
Free Cash Flow | -33.44M |
FCF Per Share | -0.64 |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
GHRS does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Payout Ratio | n/a |
Earnings Yield | -7.45% |
FCF Yield | -5.9% |
Analyst Forecast
The average price target for GHRS is $32, which is 250.5% higher than the current price. The consensus rating is "Buy".
Price Target | $32 |
Price Target Difference | 250.5% |
Analyst Consensus | Buy |
Analyst Count | 5 |
Scores
Altman Z-Score | 41.94 |
Piotroski F-Score | 2 |